Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-19-002139
Filing Date
2019-10-18
Accepted
2019-10-18 16:51:18
Documents
4
Period of Report
2019-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K essa6k.htm 6-K 9958
2 NEWS RELEASE DATED OCTOBER 18, 2019 ex991.htm EX-99.1 10583
3 GRAPHIC essalogo.jpg GRAPHIC 12032
4 GRAPHIC image_001.gif GRAPHIC 317
  Complete submission text file 0001279569-19-002139.txt   38835
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-37410 | Film No.: 191158257
SIC: 2834 Pharmaceutical Preparations